Kinesio-Taping and Chest Physiotherapy Program After Mastectomy

Efficacy of Combined Kinesio-Taping With Chest Physiotherapy Program on Pain, Pulmonary Function, Respiratory Muscle Strength and Quality of Life After Mastectomy: A Randomized Controlled Trial

The modified radical mastectomy (MRM) is a major surgical approach that necessitates the dissection of axillary lymph nodes. As a result, there is more bleeding and the treatment takes longer time. This treatment is used to treat locally advanced breast cancer. Numerous factors, including pain and respiratory depression from general anaesthesia, can impair respiratory function during the post-operative period. Pain causes the thoracic cage's post-operative movement to be restricted and the breathing muscles to become inhibited.

Study Overview

• Status: Completed
• Conditions: Mastectomy
• Intervention / Treatment: Other: Kinesiotaping; Other: chest physical therapy

Detailed Description

KT is a new technology that is being used in the treatment of post-surgical and respiratory problems, among other innovative evidence-based therapeutic options in patient care. Recently, this method is useful for treating a variety of sports-related and musculoskeletal disorders, as well as pain management. According to a small body of research on the usefulness and efficacy of KT in treating respiratory conditions in patients with chronic obstructive pulmonary disease (COPD), it can lead to improvements in respiratory muscle strength and pulmonary function.

• Study Type: Interventional
• Enrollment (Actual): 60
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Egypt
  • Giza, Egypt, 1124
    • Faculty of physical therapy

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Females aged between 30 and 50 years
• Participants after modified radical mastectomy
• Participants able to comprehend instructions.
• Cooperative participants, and willing to participate in the study.

Exclusion Criteria:

• Participants having sensitive skin, scars, or lesions.
• Participants with unhealed incisions at the site of application.
• Participants with uncontrolled diabetes.
• Participants with deep vein thrombosis.
• Participants with previous chest diseases.
• Pregnancy.
• Participants with altered sensations.
• Participants with allodynia.
• Participants with active infection.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Group A (Kinesiotaping group); Participants will be seated on a chair, KT will be applied bilaterally at the end of the expiration on the fifth to sixth and ninth to tenth intercostal muscles transversally and on the anterior and posterior axillary line longitudinally with 50% tension. In order to stimulate the muscle and support the function, the stimulation technique is usually applied from the origin to the insertion of the muscle with the recommended stretching of 25 to 50%. Additionally, traditional physical therapy program will be conducted to participants in the study group.	Other: Kinesiotaping; Participants will be seated on a chair, KT will be applied bilaterally at the end of the expiration on the fifth to sixth and ninth to tenth intercostal muscles transversally and on the anterior and posterior axillary line longitudinally with 50% tension. In order to stimulate the muscle and support the function, the stimulation technique is usually applied from the origin to the insertion of the muscle with the recommended stretching of 25 to 50%.; Other: chest physical therapy; The chest physical therapy program is consisted of deep breathing exercises, postural drainage, and cough.
Active Comparator: Group B (control group); They will receive the chest physical therapy program which is consisted of deep breathing exercises, postural drainage, cough, 3 times /week for 4 weeks.	Other: chest physical therapy; The chest physical therapy program is consisted of deep breathing exercises, postural drainage, and cough.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
visual analogue scale	The visual representation of the pain range that a patient thinks they might experience is called a linear scale. The score is ranged from 0 to 10. The least the score, the better results. While, the higher the score, the worst the results.	4 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Forced vital capacity (FVC)	The forced vital capacity (FVC) will be measured by spirometer.	4 weeks
forced expiratory volume at first second (FEV1)	forced expiratory volume at first second (FEV1) will be measured by spirometer.	4 weeks
Forced expiratory volume at first second /Forced vital capacity ratio.	Forced expiratory volume at first second /Forced vital capacity ratio will be measured by spirometer.	4 weeks
Respiratory muscle strength	Respiratory muscle strength will be measured by assessing the maximal inspiratory and maximal expiratory pressures (MIP) and maximal expiratory pressures (MEP).	4 weeks
Quality of life	Quality of life will be measured by the Short Form-36 (SF-36). It is a questionnaire with eight subscales that gives information about the health status and quality of life of the person. Scores on each subscale range from 0 to 100, with 0 corresponding to the worst health status and 100 to the best health status.	4 weeks

Collaborators and Investigators

• Sponsor: Cairo University
• Investigators: Study Director: Hadaya M Eladl, PhD, Assisstant professor of physical therapy for surgery, Faculty of physical therapy

Study record dates

Study Major Dates

• Study Start (Actual): December 20, 2024
• Primary Completion (Actual): June 30, 2025
• Study Completion (Actual): July 30, 2025

Study Registration Dates

• First Submitted: November 20, 2024
• First Submitted That Met QC Criteria: November 20, 2024
• First Posted (Actual): November 22, 2024

Study Record Updates

• Last Update Posted (Actual): August 8, 2025
• Last Update Submitted That Met QC Criteria: August 5, 2025
• Last Verified: December 1, 2024

More Information

Terms related to this study

• Keywords: pain; quality of life; physiotherapy; pulmonary function; respiratory muscle strength; kinesiotaping
• Other Study ID Numbers: No. 6905

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Sharing Time Frame: 6 months after publication
• IPD Sharing Supporting Information Type: STUDY_PROTOCOL

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No